Reuters
Australia's Telix Pharma to raise $398 mln in debt to fund cancer therapy
, opens new tab aims to raise A$600 million ($397.5 million) via the issue of convertible notes to fund key trials for its kidney and brain cancer therapy programs, the biopharmaceutical company ...
2 日前